Key result
Storage at -80 °C preserves PT and aPTT values, while -20 °C causes variable prolongation.
Why the study?
Does pre-analytical storage temperature and reagent choice affect PT and aPTT measurements in plasma samples?
Observational (n=42)
Does pre-analytical storage temperature and reagent choice affect PT and aPTT measurements in plasma samples?
Answers are grounded in this paper and cite their sources.
Accurate interpretation of PT and aPTT requires optimal sample handling (storage at -80 °C or LN₂) and awareness of reagent-specific sensitivities, particularly for anticoagulated patients.
BACKGROUND: Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are widely used coagulation assays whose results can vary due to pre-analytical and analytical factors. Understanding these sources of variability is essential for reliable laboratory practice and external quality assessment (EQA). OBJECTIVES: This study evaluates the impact of pre-analytical storage and method-dependent sensitivity on PT and aPTT measurements and provides guidance for EQA programmes and clinical interpretation. METHODS: Plasma samples from 42 healthy volunteers were analysed within 4 h of collection or after storage at -20 °C, -80 °C, or snap-frozen in liquid nitrogen (LN₂) and subsequent storage at -80 °C. Additionally, pooled plasma was spiked with direct oral anticoagulants, heparins, and lupus anticoagulant antibodies to assess reagent-specific sensitivity. PT and aPTT were measured on multiple routine platforms using commonly used reagents from 4 different manufacturers. RESULTS: Storage at -80 °C or LN₂ preserved PT and aPTT values, whereas storage at -20 °C caused variable prolongation. In healthy volunteers, PT and aPTT showed marked inter-method variability. Sensitivity to anticoagulants and lupus anticoagulant also differed considerably between reagents, with the largest variation observed for edoxaban. This study provides an overview of inter-method variability, which may affect clinical decision-making and inter-laboratory comparability. CONCLUSIONS: PT and aPTT are screening tests whose accurate interpretation depends on optimal sample handling and awareness of reagent- and method-specific sensitivities. These differences can affect clinical decision-making in anticoagulated patients. EQA programmes could increase their value by using frozen plasma, including clinically relevant anticoagulants, and implementing case-based scenarios rather than reporting only clotting times.
No takes yet. Share an insight, caveat, or question.
Dam et al. (2026) conducted an observational in Healthy volunteers (n=42). Pre-analytical storage (-20 °C, -80 °C, or liquid nitrogen) and different reagents vs. Analysis within 4 hours of collection was evaluated on Prothrombin time (PT) and activated partial thromboplastin time (aPTT) measurements. Storage at -80 °C or liquid nitrogen preserved PT and aPTT values, whereas storage at -20 °C caused variable prolongation, with marked inter-method and reagent-specific variability observed.
Synapse has enriched 10 related papers. Consider them for comparative context: